Direct Rx recalls
1 recall filed under Direct Rx. The most recent was published July 1, 2026.
-
Class II · 4 months ago
Direct Rx Duloxetine D/R, a) 30 mg , 30 Caps recall: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA recommended interim limit
About this page
Direct Rx appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.